This is a StreetInsider.com Premium Only Page

Outlook Therapeutics (OTLK) –

Apr 17, 2024 09:39 PM Form SC 13D/A Outlook Therapeutics, Filed by: Syntone Ventures LLC

Apr 17, 2024 08:22 PM Form 4 Outlook Therapeutics, For: Apr 15 Filed by: Syntone Ventures LLC

Apr 16, 2024 05:22 PM Form D Outlook Therapeutics,

Apr 15, 2024 04:54 PM Form 8-K Outlook Therapeutics, For: Apr 15

Apr 15, 2024 04:15 PM Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million

Apr 12, 2024 04:27 PM Form 424B5 Outlook Therapeutics,

Apr 12, 2024 04:05 PM Form 8-K Outlook Therapeutics, For: Apr 12

Apr 8, 2024 04:11 PM Form SC 13G Outlook Therapeutics, Filed by: GREAT POINT PARTNERS LLC

Apr 8, 2024 06:03 AM Form EFFECT Outlook Therapeutics,

Apr 2, 2024 04:19 PM Outlook Therapeutics (OTLK) Receives Nasdaq Non-compliance Notice

Apr 2, 2024 04:16 PM Form 8-K Outlook Therapeutics, For: Apr 01

Apr 2, 2024 06:05 AM Form EFFECT Outlook Therapeutics,

Apr 1, 2024 04:54 PM Form 424B3 Outlook Therapeutics,

Mar 29, 2024 02:17 PM Form D Outlook Therapeutics,

Mar 29, 2024 10:39 AM Form 4 Outlook Therapeutics, For: Mar 28 Filed by: Haddadin Yezan Munther

Mar 28, 2024 05:08 PM Form S-8 Outlook Therapeutics,

Mar 28, 2024 05:05 PM Outlook Therapeutics (OTLK) Files $300M Mixed Shelf

Mar 28, 2024 05:04 PM Form S-3 Outlook Therapeutics,

Mar 28, 2024 04:23 PM Form SC 13G Outlook Therapeutics, Filed by: Velan Capital Investment Management LP

Mar 28, 2024 04:01 PM Form SC 13G Outlook Therapeutics, Filed by: TANG CAPITAL PARTNERS LP

Mar 27, 2024 08:15 AM BTIG Upgrades Outlook Therapeutics Incs. (OTLK) to Buy

Mar 26, 2024 04:20 PM Form 8-K Outlook Therapeutics, For: Mar 20

Mar 26, 2024 06:36 AM Outlook Therapeutics Incs. (OTLK) PT Raised to $30 at H.C. Wainwright

Mar 25, 2024 04:15 PM Outlook Therapeutics (OTLK) Announces 21.43M Share Offering by Selling Stockholders

Mar 25, 2024 04:12 PM Form S-3 Outlook Therapeutics,

Mar 22, 2024 05:01 PM Form 4 Outlook Therapeutics, For: Mar 20 Filed by: KENYON LAWRENCE A

Mar 22, 2024 05:01 PM Form 4 Outlook Therapeutics, For: Mar 20 Filed by: Evanson Jeff

Mar 22, 2024 05:00 PM Form 4 Outlook Therapeutics, For: Mar 20 Filed by: TRENARY C RUSSELL III

Mar 22, 2024 07:36 AM Outlook Therapeutics (OTLK) Receives EU Positive CHMP Opinion for ONS-5010

Mar 22, 2024 07:35 AM Outlook Therapeutics® Receives European Union Positive CHMP Opinion for ONS-5010 as a Treatment for Wet AMD

Mar 20, 2024 05:24 PM Form SC 13D/A Outlook Therapeutics, Filed by: GMS Ventures & Investments

Mar 20, 2024 05:20 PM Form 4 Outlook Therapeutics, For: Mar 18 Filed by: Sukhtian Ghiath M.

Mar 18, 2024 05:14 PM Form 8-K Outlook Therapeutics, For: Mar 13

Mar 18, 2024 05:10 PM Outlook Therapeutics® Announces Closing of Private Placement of up to $159 Million

Mar 12, 2024 08:05 AM Outlook Therapeutics (OTLK) Announces Effective Date for 1-for-20 Reverse Stock Split

Mar 12, 2024 08:05 AM Outlook Therapeutics® Announces Effective Date for 1-for-20 Reverse Stock Split

Mar 11, 2024 04:43 PM Form 4 Outlook Therapeutics, For: Mar 07 Filed by: Evanson Jeff

Mar 8, 2024 04:31 PM Form 4 Outlook Therapeutics, For: Mar 07 Filed by: Haller Julia A

Mar 8, 2024 04:19 PM Form 4 Outlook Therapeutics, For: Mar 07 Filed by: Huang Andong

Mar 8, 2024 04:15 PM Form 4 Outlook Therapeutics, For: Mar 07 Filed by: Auffarth Gerd

Mar 8, 2024 04:13 PM Form 4 Outlook Therapeutics, For: Mar 07 Filed by: Gangolli Julian S

Mar 8, 2024 04:11 PM Form 4 Outlook Therapeutics, For: Mar 07 Filed by: Haddadin Yezan Munther

Mar 8, 2024 04:09 PM Form 4 Outlook Therapeutics, For: Mar 07 Filed by: Sukhtian Faisal Ghiath

Mar 8, 2024 04:07 PM Form 4 Outlook Therapeutics, For: Mar 07 Filed by: HILZINGER KURT J

Mar 8, 2024 04:05 PM Form 4 Outlook Therapeutics, For: Mar 07 Filed by: THURMAN RANDY H

Mar 7, 2024 04:17 PM Form 8-K Outlook Therapeutics, For: Mar 07

Feb 23, 2024 05:51 AM Outlook Therapeutics Incs. (OTLK) PT Raised to $2.25 at Ascendiant Capital

Feb 15, 2024 07:14 AM Chardan Capital Markets Upgrades Outlook Therapeutics Incs. (OTLK) to Buy, 'Outlook Is Bright Again'

Feb 15, 2024 06:40 AM Outlook Therapeutics Incs. (OTLK) PT Lowered to $1.50 at H.C. Wainwright

Feb 14, 2024 05:11 PM Form 10-Q Outlook Therapeutics, For: Dec 31